APO RESEARCH · REPORT
Implantable Neurostimulators
An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician’s programmer, Patient’s programmer.
Product & engineering
Understand the product.
An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician’s programmer, Patient’s programmer.
Selected research
Industry Growth & Trends
Global Implantable Neurostimulators Industry Growth and Trends Forecast to 2032
Market perspective
An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician’s programmer, Patient’s programmer.
The major players in United States Implantable Neurostimulators market include Medtronic, Boston Scientific, etc. The top 2 players occupy about 60% shares of the whole market. Mid-Atlantic Region and South Atlantic are main markets, they occupy about 40% of the whole market. Spinal Cord Stimulators is the main type, with a share about 55%. Pain is the main application, which holds a share about 55%.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Implantable Neurostimulators market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Implantable Neurostimulators market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Implantable Neurostimulators market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Implantable Neurostimulators.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Implantable Neurostimulators market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Implantable Neurostimulators Market by Company
Medtronic
Boston Scientific
St. Jude Medical
Cyberonics
NeuroPace
Synapse Biomedical
NeuroSigma
ReShape Lifesciences
ElectroCore Medical
Inspire Medical
NEUROS
SPR
IMTHERA
NEVRO
Implantable Neurostimulators Segment by Type
Deep Brain Stimulators
Spinal Cord Stimulators
Vagal Nerve Stimulators
Sacral Nerve Stimulators
Gastric Stimulators
Others
Implantable Neurostimulators Segment by Application
Parkinson's Disease
Epilepsy
Pain
Others
Implantable Neurostimulators Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Neurostimulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Implantable Neurostimulators and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Neurostimulators.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Implantable Neurostimulators manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Implantable Neurostimulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Deep Brain Stimulators
- Spinal Cord Stimulators
- Vagal Nerve Stimulators
- Sacral Nerve Stimulators
- Gastric Stimulators
- Others
Applications
- Parkinson's Disease
- Epilepsy
- Pain
- Others
Companies covered
- Medtronic
- Boston Scientific
- St. Jude Medical
- Cyberonics
- NeuroPace
- Synapse Biomedical
- NeuroSigma
- ReShape Lifesciences
- ElectroCore Medical
- Inspire Medical
- NEUROS
- SPR
- IMTHERA
- NEVRO
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Implantable Neurostimulators Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Implantable Neurostimulators Sales Estimates and Forecasts (2021-2032)
- 1.3 Implantable Neurostimulators Market by Type
- 1.3.1 Deep Brain Stimulators
- 1.3.2 Spinal Cord Stimulators
- 1.3.3 Vagal Nerve Stimulators
- 1.3.4 Sacral Nerve Stimulators
- 1.3.5 Gastric Stimulators
- 1.3.6 Others
- 1.4 Global Implantable Neurostimulators Market Size by Type
- 1.4.1 Global Implantable Neurostimulators Market Size Overview by Type (2021-2032)
- 1.4.2 Global Implantable Neurostimulators Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Implantable Neurostimulators Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Implantable Neurostimulators Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Implantable Neurostimulators Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Implantable Neurostimulators Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Implantable Neurostimulators Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Implantable Neurostimulators Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Implantable Neurostimulators Industry Trends
- 2.2 Implantable Neurostimulators Industry Drivers
- 2.3 Implantable Neurostimulators Industry Opportunities and Challenges
- 2.4 Implantable Neurostimulators Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Implantable Neurostimulators Revenue (2021-2026)
- 3.2 Global Top Players by Implantable Neurostimulators Sales (2021-2026)
- 3.3 Global Top Players by Implantable Neurostimulators Price (2021-2026)
- 3.4 Global Implantable Neurostimulators Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Implantable Neurostimulators Major Company Production Sites & Headquarters
- 3.6 Global Implantable Neurostimulators Company, Product Type & Application
- 3.7 Global Implantable Neurostimulators Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Implantable Neurostimulators Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Implantable Neurostimulators Players Market Share by Revenue in 2025
- 3.8.3 2025 Implantable Neurostimulators Tier 1, Tier 2, and Tier 3
4 Implantable Neurostimulators Regional Status and Outlook
- 4.1 Global Implantable Neurostimulators Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Implantable Neurostimulators Historic Market Size by Region
- 4.2.1 Global Implantable Neurostimulators Sales in Volume by Region (2021-2026)
- 4.2.2 Global Implantable Neurostimulators Sales in Value by Region (2021-2026)
- 4.2.3 Global Implantable Neurostimulators Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Implantable Neurostimulators Forecasted Market Size by Region
- 4.3.1 Global Implantable Neurostimulators Sales in Volume by Region (2027-2032)
- 4.3.2 Global Implantable Neurostimulators Sales in Value by Region (2027-2032)
- 4.3.3 Global Implantable Neurostimulators Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Implantable Neurostimulators by Application
- 5.1 Implantable Neurostimulators Market by Application
- 5.1.1 Parkinson's Disease
- 5.1.2 Epilepsy
- 5.1.3 Pain
- 5.1.4 Others
- 5.2 Global Implantable Neurostimulators Market Size by Application
- 5.2.1 Global Implantable Neurostimulators Market Size Overview by Application (2021-2032)
- 5.2.2 Global Implantable Neurostimulators Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Implantable Neurostimulators Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Implantable Neurostimulators Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Implantable Neurostimulators Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Implantable Neurostimulators Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Implantable Neurostimulators Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Implantable Neurostimulators Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Medtronic
- 6.1.1 Medtronic Company Information
- 6.1.2 Medtronic Business Overview
- 6.1.3 Medtronic Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Medtronic Implantable Neurostimulators Product Portfolio
- 6.1.5 Medtronic Recent Developments
- 6.2 Boston Scientific
- 6.2.1 Boston Scientific Company Information
- 6.2.2 Boston Scientific Business Overview
- 6.2.3 Boston Scientific Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Boston Scientific Implantable Neurostimulators Product Portfolio
- 6.2.5 Boston Scientific Recent Developments
- 6.3 St. Jude Medical
- 6.3.1 St. Jude Medical Company Information
- 6.3.2 St. Jude Medical Business Overview
- 6.3.3 St. Jude Medical Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 St. Jude Medical Implantable Neurostimulators Product Portfolio
- 6.3.5 St. Jude Medical Recent Developments
- 6.4 Cyberonics
- 6.4.1 Cyberonics Company Information
- 6.4.2 Cyberonics Business Overview
- 6.4.3 Cyberonics Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Cyberonics Implantable Neurostimulators Product Portfolio
- 6.4.5 Cyberonics Recent Developments
- 6.5 NeuroPace
- 6.5.1 NeuroPace Company Information
- 6.5.2 NeuroPace Business Overview
- 6.5.3 NeuroPace Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 NeuroPace Implantable Neurostimulators Product Portfolio
- 6.5.5 NeuroPace Recent Developments
- 6.6 Synapse Biomedical
- 6.6.1 Synapse Biomedical Company Information
- 6.6.2 Synapse Biomedical Business Overview
- 6.6.3 Synapse Biomedical Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Synapse Biomedical Implantable Neurostimulators Product Portfolio
- 6.6.5 Synapse Biomedical Recent Developments
- 6.7 NeuroSigma
- 6.7.1 NeuroSigma Company Information
- 6.7.2 NeuroSigma Business Overview
- 6.7.3 NeuroSigma Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 NeuroSigma Implantable Neurostimulators Product Portfolio
- 6.7.5 NeuroSigma Recent Developments
- 6.8 ReShape Lifesciences
- 6.8.1 ReShape Lifesciences Company Information
- 6.8.2 ReShape Lifesciences Business Overview
- 6.8.3 ReShape Lifesciences Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 ReShape Lifesciences Implantable Neurostimulators Product Portfolio
- 6.8.5 ReShape Lifesciences Recent Developments
- 6.9 ElectroCore Medical
- 6.9.1 ElectroCore Medical Company Information
- 6.9.2 ElectroCore Medical Business Overview
- 6.9.3 ElectroCore Medical Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 ElectroCore Medical Implantable Neurostimulators Product Portfolio
- 6.9.5 ElectroCore Medical Recent Developments
- 6.10 Inspire Medical
- 6.10.1 Inspire Medical Company Information
- 6.10.2 Inspire Medical Business Overview
- 6.10.3 Inspire Medical Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Inspire Medical Implantable Neurostimulators Product Portfolio
- 6.10.5 Inspire Medical Recent Developments
- 6.11 NEUROS
- 6.11.1 NEUROS Company Information
- 6.11.2 NEUROS Business Overview
- 6.11.3 NEUROS Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 NEUROS Implantable Neurostimulators Product Portfolio
- 6.11.5 NEUROS Recent Developments
- 6.12 SPR
- 6.12.1 SPR Company Information
- 6.12.2 SPR Business Overview
- 6.12.3 SPR Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 SPR Implantable Neurostimulators Product Portfolio
- 6.12.5 SPR Recent Developments
- 6.13 IMTHERA
- 6.13.1 IMTHERA Company Information
- 6.13.2 IMTHERA Business Overview
- 6.13.3 IMTHERA Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 IMTHERA Implantable Neurostimulators Product Portfolio
- 6.13.5 IMTHERA Recent Developments
- 6.14 NEVRO
- 6.14.1 NEVRO Company Information
- 6.14.2 NEVRO Business Overview
- 6.14.3 NEVRO Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 NEVRO Implantable Neurostimulators Product Portfolio
- 6.14.5 NEVRO Recent Developments
7 North America by Country
- 7.1 North America Implantable Neurostimulators Sales by Country
- 7.1.1 North America Implantable Neurostimulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Implantable Neurostimulators Sales by Country (2021-2026)
- 7.1.3 North America Implantable Neurostimulators Sales Forecast by Country (2027-2032)
- 7.2 North America Implantable Neurostimulators Market Size by Country
- 7.2.1 North America Implantable Neurostimulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Implantable Neurostimulators Market Size by Country (2021-2026)
- 7.2.3 North America Implantable Neurostimulators Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Implantable Neurostimulators Sales by Country
- 8.1.1 Europe Implantable Neurostimulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Implantable Neurostimulators Sales by Country (2021-2026)
- 8.1.3 Europe Implantable Neurostimulators Sales Forecast by Country (2027-2032)
- 8.2 Europe Implantable Neurostimulators Market Size by Country
- 8.2.1 Europe Implantable Neurostimulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Implantable Neurostimulators Market Size by Country (2021-2026)
- 8.2.3 Europe Implantable Neurostimulators Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Implantable Neurostimulators Sales by Country
- 9.1.1 Asia-Pacific Implantable Neurostimulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Implantable Neurostimulators Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Implantable Neurostimulators Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Implantable Neurostimulators Market Size by Country
- 9.2.1 Asia-Pacific Implantable Neurostimulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Implantable Neurostimulators Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Implantable Neurostimulators Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Implantable Neurostimulators Sales by Country
- 10.1.1 South America Implantable Neurostimulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Implantable Neurostimulators Sales by Country (2021-2026)
- 10.1.3 South America Implantable Neurostimulators Sales Forecast by Country (2027-2032)
- 10.2 South America Implantable Neurostimulators Market Size by Country
- 10.2.1 South America Implantable Neurostimulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Implantable Neurostimulators Market Size by Country (2021-2026)
- 10.2.3 South America Implantable Neurostimulators Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Implantable Neurostimulators Sales by Country
- 11.1.1 Middle East and Africa Implantable Neurostimulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Implantable Neurostimulators Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Implantable Neurostimulators Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Implantable Neurostimulators Market Size by Country
- 11.2.1 Middle East and Africa Implantable Neurostimulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Implantable Neurostimulators Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Implantable Neurostimulators Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Implantable Neurostimulators Value Chain Analysis
- 12.1.1 Implantable Neurostimulators Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Implantable Neurostimulators Production Mode & Process
- 12.2 Implantable Neurostimulators Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Implantable Neurostimulators Distributors
- 12.2.3 Implantable Neurostimulators Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst